{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T05:02:32Z","timestamp":1770613352961,"version":"3.49.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.clindermatol.2013.01.011","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T10:30:22Z","timestamp":1372156222000},"page":"438-454","source":"Crossref","is-referenced-by-count":71,"title":["Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: Facts and controversies"],"prefix":"10.1016","volume":"31","author":[{"given":"Thilo","family":"Gambichler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Terras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2013.01.011_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2133.1978.tb07328.x","article-title":"A new apparatus for the delivery of high intensity UVA and UVA+UVB irradiation, and some dermatological applications","volume":"98","author":"Plewig","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1523-1747.ep12524813","article-title":"A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications","volume":"76","author":"Mutzhas","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1046\/j.1365-2230.2000.00700.x","article-title":"Phototherapy for atopic dermatitis","volume":"25","author":"Krutmann","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00128071-200910030-00003","article-title":"Immunologically mediated photodermatoses: diagnosis and treatment","volume":"10","author":"Gambichler","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2008.07.042","article-title":"Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review","volume":"59","author":"Kroft","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00403-008-0923-5","article-title":"Management of atopic dermatitis using photo(chemo)therapy","volume":"301","author":"Gambichler","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0035","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.2008.08672.x","article-title":"UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V","volume":"159","author":"Jacobe","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0781.2008.00328.x","article-title":"Efficacy of UVA1 phototherapy in 230 patients with various skin diseases","volume":"24","author":"Rombold","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0781.2007.00291.x","article-title":"Phototherapy in the management of atopic dermatitis: a systematic review","volume":"23","author":"Meduri","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/rheumatology\/kel063","article-title":"Light therapy (with UVA-1) for SLE patients: is it a good or bad idea?","volume":"45","author":"Pavel","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0055","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1365-2133.2003.05261.x","article-title":"Ultraviolet A1 phototherapy","volume":"148","author":"Dawe","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0781.2006.00245.x","article-title":"UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States","volume":"22","author":"Tuchinda","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2010.22.1.1","article-title":"Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases","volume":"22","author":"Suh","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-4632.2009.04427.x","article-title":"UVA1 phototherapy: a review of mechanism and therapeutic application","volume":"49","author":"York","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1396-0296.2003.01642.x","article-title":"Phototherapy for cutaneous T-cell lymphoma","volume":"16","author":"Baron","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0080","series-title":"Photodermatology","author":"Lim","year":"2007"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0190-9622(99)70249-5","article-title":"Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis","volume":"41","author":"von Kobyletzki","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0781.2005.00150.x","article-title":"UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center","volume":"21","author":"Polderman","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1751-1097.2011.01043.x","article-title":"Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-thioguanine","volume":"88","author":"Brem","year":"2011","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0100","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archderm.141.12.1549","article-title":"Dose-response and time-course characteristics of UV-A1 erythema","volume":"141","author":"Beattie","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0378-6323.69074","article-title":"Phototherapy and photochemotherapy in childhood dermatoses","volume":"76","author":"Dogra","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2230.2011.04256.x","article-title":"Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report","volume":"37","author":"Kerr","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0190-9622(92)70031-A","article-title":"High-dose UVA1 therapy in the treatment of patients with atopic dermatitis","volume":"26","author":"Krutmann","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0190-9622(98)70123-9","article-title":"High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial","volume":"38","author":"Krutmann","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1067\/mjd.2001.114743","article-title":"High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis","volume":"45","author":"Tzaneva","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s001050051336","article-title":"UVA1 phototherapy. Pilot study of dose finding in acute exacerbated atopic dermatitis","volume":"52","author":"Dittmar","year":"2001","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2340\/00015555754345","article-title":"Low dose versus medium dose UV-A1 treatment in severe atopic dermatitis","volume":"75","author":"Kowalzick","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s001050050638","article-title":"Responders and nonresponders of ultraviolet A-1 therapy of acute exacerbated atopic dermatitis","volume":"48","author":"Kowalzick","year":"1997","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0190-9622(00)90134-8","article-title":"Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis","volume":"42","author":"Abeck","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.139.2.223","article-title":"Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis","volume":"139","author":"Legat","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0155","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2133.2008.08984.x","article-title":"Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic dermatitis: a randomized crossover study","volume":"160","author":"Gambichler","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaad.2008.08.048","article-title":"Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis","volume":"60","author":"Majoie","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0165","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2133.2009.09514.x","article-title":"5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial","volume":"162","author":"Tzaneva","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0190-9622(03)00782-5","article-title":"Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic dermatitis","volume":"50","author":"Petering","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0175","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/000155598442089","article-title":"UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand dermatitis","volume":"78","author":"Schmidt","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0180","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2230.2003.01378.x","article-title":"A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic dermatitis","volume":"28","author":"Polderman","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.jidsp.5640185","article-title":"Mechanisms of ultraviolet (UV) B and UVA phototherapy","volume":"4","author":"Krutmann","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0190","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.186.10.1763","article-title":"Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy","volume":"186","author":"Morita","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0195","first-page":"315","article-title":"Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy","volume":"7","author":"Breuckmann","year":"2002","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-5945-2-12","article-title":"Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy","volume":"2","author":"Breuckmann","year":"2002","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0205","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2133.2008.08498.x","article-title":"Gene expression of cytokines in atopic dermatitis before and after ultraviolet A1 phototherapy","volume":"158","author":"Gambichler","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/archderm.136.2.275","article-title":"Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy","volume":"136","author":"von Kobyletzki","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0215","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1067\/mjd.2000.105165","article-title":"Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis","volume":"43","author":"Morita","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-5945-3-2","article-title":"Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: immunohistochemical analysis of 3 cases","volume":"3","author":"Sawada","year":"2003","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0225","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaad.2003.08.026","article-title":"Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis","volume":"50","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0230","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1468-3083.2011.04137.x","article-title":"Low-dose UVA(1) phototherapy for scleroderma: what benefit can we expect?","volume":"26","author":"Pereira","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0781.2009.00422.x","article-title":"Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis","volume":"25","author":"Rose","year":"2009","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0781.2011.00570.x","article-title":"Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis","volume":"27","author":"Tewari","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-0781.2007.00308.x","article-title":"Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis","volume":"23","author":"Durand","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0250","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.annder.2008.12.022","article-title":"Treatment of connective tissue disorder-related acral syndromes using UVA-1 phototherapy. An open study of 11 cases","volume":"136","author":"Comte","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0255","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(97)80277-0","article-title":"High-dose UVA1 radiation therapy for localized scleroderma","volume":"36","author":"Stege","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0260","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(95)91843-4","article-title":"Treatment of localised scleroderma by UVA1 phototherapy","volume":"346","author":"Kerscher","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-0781.2001.170401.x","article-title":"Effects of low dose ultraviolet A-1 phototherapy on morphea","volume":"17","author":"Gruss","year":"2001","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0270","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1067\/mjd.2001.117735","article-title":"Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells","volume":"45","author":"Camacho","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0275","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000073093","article-title":"Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method","volume":"207","author":"de Rie","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0280","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0285","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2008.12.013","article-title":"Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment","volume":"60","author":"Sator","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0290","doi-asserted-by":"crossref","unstructured":"Su O, Onsun N, Onay HK, Erdemoglu Y, Ozkaya DB, Cebeci F, et al. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma. Int J Dermatol;50:1006-13.","DOI":"10.1111\/j.1365-4632.2010.04843.x"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0295","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2009.09438.x","article-title":"Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study","volume":"162","author":"Andres","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0300","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2133.1997.tb14925.x","article-title":"Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood","volume":"136","author":"Gruss","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2230.2001.00754.x","article-title":"Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus","volume":"26","author":"Kreuter","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mjd.2002.118552","article-title":"Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study","volume":"46","author":"Kreuter","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0315","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2230.2006.02082.x","article-title":"UVA1 phototherapy for genital lichen sclerosus","volume":"31","author":"Beattie","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0320","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(00)90023-9","article-title":"Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy","volume":"42","author":"Grundmann-Kollmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0325","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1067\/mjd.2002.121352","article-title":"UVA1 therapy for sclerodermic graft-versus-host disease of the skin","volume":"46","author":"Stander","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0330","first-page":"1169","article-title":"Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease","volume":"88","author":"Calzavara Pinton","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0335","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.bmt.1704804","article-title":"Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin","volume":"35","author":"Wetzig","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0340","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/bmt.2010.230","article-title":"UVA (UVA-1) therapy for the treatment of acute GVHD of the skin","volume":"45","author":"Schlaak","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0345","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaad.2004.02.011","article-title":"Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life","volume":"51","author":"Ziemer","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0350","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archdermatol.2009.245","article-title":"UV-A1 therapy for nephrogenic systemic fibrosis","volume":"145","author":"Tran","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0355","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archderm.140.11.1322","article-title":"UV-A1 phototherapy improves nephrogenic fibrosing dermopathy","volume":"140","author":"Kafi","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0360","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.144.11.1527","article-title":"Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis","volume":"144","author":"Kreuter","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0365","first-page":"501","article-title":"Outcome measurements in scleroderma: results from a delphi exercise","volume":"34","author":"Gazi","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0370","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archderm.144.7.912","article-title":"UV-A1 phototherapy for sclerotic skin diseases: implications for optimizing patient selection and management","volume":"144","author":"Kreuter","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0375","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-5945-4-11","article-title":"UVA\/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review","volume":"4","author":"Breuckmann","year":"2004","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0380","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaad.2006.10.961","article-title":"Differential expression of decorin in localized scleroderma following ultraviolet-A1 irradiation","volume":"56","author":"Gambichler","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0385","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00403-006-0695-8","article-title":"Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma","volume":"298","author":"Kreuter","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0390","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2133.2006.07391.x","article-title":"Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma","volume":"155","author":"Kreuter","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0395","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1346-8138.2003.tb00368.x","article-title":"The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis","volume":"30","author":"Yin","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0400","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2133.2007.07802.x","article-title":"Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation","volume":"156","author":"Gambichler","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0190-9622(99)70405-6","article-title":"Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma","volume":"41","author":"Plettenberg","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0410","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mjd.2001.110896","article-title":"\"High-dose\" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides","volume":"44","author":"Zane","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0415","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1067\/mjd.2000.108370","article-title":"Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma?","volume":"43","author":"Stander","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0420","first-page":"768","article-title":"Ultraviolet-A1 phototherapy improves the status of the skin in cutaneous T-cell lymphoma","volume":"140","author":"von Kobyletzki","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0425","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2004.09.036","article-title":"Medium-dose UVA1 therapy of lymphomatoid papulosis","volume":"52","author":"Calzavara-Pinton","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0430","first-page":"390","article-title":"UVA1 cold-light phototherapy of small plaque parapsoriasis","volume":"80","author":"Kreuter","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0435","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1525-1470.2005.22119.x","article-title":"Hypopigmented mycosis fungoides in a child successfully treated with UVA1-light","volume":"22","author":"Roupe","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0440","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000226135","article-title":"Granulomatous slack skin responds to UVA1 phototherapy","volume":"219","author":"Oberholzer","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0445","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1034\/j.1600-0781.2000.160607.x","article-title":"UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneous T-cell lymphoma in vivo","volume":"16","author":"von Kobyletzki","year":"2000","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0450","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0781.2002.02740.x","article-title":"Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study","volume":"18","author":"Breuckmann","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0455","first-page":"129","article-title":"Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus","volume":"12","author":"McGrath","year":"1994","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.clindermatol.2013.01.011_bb0460","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/096120339600500405","article-title":"Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus","volume":"5","author":"McGrath","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0465","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/ard.60.2.112","article-title":"UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial","volume":"60","author":"Polderman","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0470","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/rheumatology\/keh352","article-title":"Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus","volume":"43","author":"Polderman","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0475","first-page":"1072","article-title":"Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus","volume":"24","author":"Molina","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0480","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1191\/0961203303lu374oa","article-title":"Reversal of brain dysfunction with UV-A1 irradiation in a patient with systemic lupus","volume":"12","author":"Menon","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0485","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1191\/0961203305lu2164cr","article-title":"Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient","volume":"14","author":"McGrath","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0490","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/rheumatology\/keh643","article-title":"Ultraviolet-A1 phototherapy modulates Th1\/Th2 and Tc1\/Tc2 balance in patients with systemic lupus erythematosus","volume":"44","author":"Szegedi","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0495","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2249.2006.03136.x","article-title":"Ultraviolet-A (UVA-1) radiation suppresses immunoglobulin production of activated B lymphocytes in vitro","volume":"145","author":"Polderman","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0500","first-page":"39","article-title":"The protective effects of ultraviolet A1 irradiation on spontaneous lupus erythematosus-like skin lesions in MRL\/lpr mice","volume":"67","author":"Mikita","year":"2009","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0505","first-page":"723","article-title":"UV-A-1 therapy of subacute cutaneous lupus erythematosus","volume":"44","author":"Sonnichsen","year":"1993","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0510","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2230.2005.02030.x","article-title":"A trial of low-dose UVA1 phototherapy for two patients with recalcitrant discoid lupus erythematosus","volume":"31","author":"Mitra","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0515","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(96)91600-1","article-title":"High-dose UVA1 for urticaria pigmentosa","volume":"347","author":"Stege","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0520","first-page":"561","article-title":"Induction of apoptosis in skin-infiltrating mast cells by high-dose ultraviolet-A-1 (UVA-1) radiation phototherapy in patients with urticaria pigmentosa","volume":"112","author":"Stege","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0525","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/S0190-9622(03)01483-X","article-title":"Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study","volume":"49","author":"Gobello","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0530","first-page":"389","article-title":"Versagen von Mittel- und Hochdosis-UV-A1 bei zwei F\u00e4llen von Urticaria pigmentosa","volume":"25","author":"Kowalzick","year":"1999","journal-title":"Akt Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0535","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0781.2010.00543.x","article-title":"Dramatic response of chronic ulcerating necrobiosis lipoidica to ultraviolet A1 phototherapy","volume":"26","author":"Radakovic","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0540","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2230.2005.02059.x","article-title":"UVA1 phototherapy for treatment of necrobiosis lipoidica","volume":"31","author":"Beattie","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0545","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2003.09.027","article-title":"Cutaneous sarcoidosis treated with medium-dose UVA1","volume":"50","author":"Mahnke","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0550","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-2133.2001.04356.x","article-title":"Successful ultraviolet A1 treatment of cutaneous sarcoidosis","volume":"145","author":"Graefe","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0555","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archderm.1997.03890480131025","article-title":"Phototherapy with UV-A-I for generalized granuloma annulare","volume":"133","author":"Muchenberger","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0560","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2230.2007.02530.x","article-title":"Multiple localized granuloma annulare: ultraviolet A1 phototherapy","volume":"32","author":"Frigerio","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0565","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0781.2005.00145.x","article-title":"UVA1 phototherapy for disseminated granuloma annulare","volume":"21","author":"Schnopp","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0570","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2230.2006.02081.x","article-title":"A randomised controlled trial on photo(chemo)therapy of subacute prurigo","volume":"31","author":"Gambichler","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0575","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5021\/ad.2009.21.3.230","article-title":"Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea","volume":"21","author":"Lim","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0580","first-page":"73","article-title":"Ultraviolet light hardening in polymorphous light eruption\u2013a controlled study comparing different emission spectra","volume":"8","author":"Rucker","year":"1991","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0585","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000018440","article-title":"Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy","volume":"201","author":"von Kobyletzki","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0590","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/000155500750043087","article-title":"UVA1 for hypereosinophilic syndrome","volume":"80","author":"Plotz","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0595","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1067\/mjd.2001.117248","article-title":"Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy","volume":"45","author":"Schaller","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0600","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mjd.2002.122199","article-title":"Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica","volume":"47","author":"Pinton","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0605","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1468-3083.2005.00935.x","article-title":"Successful UVA1 phototherapy in a patient with scleredema adultorum","volume":"19","author":"Eberlein-Konig","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0610","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archderm.144.7.947","article-title":"Scleredema diabeticorum case series: successful treatment with UV-A1","volume":"144","author":"Kroft","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0615","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00105-011-2150-9","article-title":"Scleredema diabeticorum: successful treatment with UVA-1 phototherapy","volume":"62","author":"Kochs","year":"2011","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0620","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00015550310015437","article-title":"UVA1 phototherapy of Netherton syndrome","volume":"84","author":"Capezzera","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0625","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00105-002-0448-3","article-title":"Pansclerotic porphyria cutanea tarda after chronic exposure to organic solvents","volume":"54","author":"Karamfilov","year":"2003","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0630","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archderm.140.6.660","article-title":"Treatment of reticular erythematous mucinosis with UV-A1 radiation","volume":"140","author":"Meewes","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0635","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1468-3083.2007.02576.x","article-title":"Period of remission after treatment with UVA-1 in sclerodermic skin diseases","volume":"22","author":"Kroft","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0640","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0781.2004.00106.x","article-title":"UVA-1 as a treatment for scleredema","volume":"20","author":"Janiga","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0645","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/000155599750010076","article-title":"UVA1 for treatment of keloids","volume":"79","author":"Hannuksela-Svahn","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0650","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/archderm.135.3.348","article-title":"UV-A1 for keloid","volume":"135","author":"Asawanonda","year":"1999","journal-title":"Arch Dermatl"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0655","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0781.2009.00463.x","article-title":"Eosinophilic fascitis: a report of two cases treated with ultraviolet A1 phototherapy","volume":"25","author":"Silny","year":"2009","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0660","series-title":"Phototherapy and Photodiagnostic Methods","year":"2001"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0665","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s001050050817","article-title":"Bleomycin-induced PSS-like pseudoscleroderma. Case report and review of the literature","volume":"49","author":"Behrens","year":"1998","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0670","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2133.2000.03388.x","article-title":"Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris","volume":"142","author":"Herbst","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0675","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0781.2011.00643.x","article-title":"A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo","volume":"28","author":"El-Zawahry","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0680","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.sder.2011.08.002","article-title":"Ultraviolet A radiation: its role in immunosuppression and carcinogenesis","volume":"30","author":"Halliday","year":"2011","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0685","first-page":"657","article-title":"An action spectrum for ultraviolet radiation-induced immunosuppression in humans","volume":"164","author":"Damian","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0690","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1751-1097.2010.00746.x","article-title":"Nicotinamide prevents ultraviolet radiation-induced cellular energy loss","volume":"86","author":"Park","year":"2010","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0695","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0781.2010.00529.x","article-title":"Merkel cell carcinoma arising in immunosuppressed patients treated with high-dose ultraviolet A1 (320-400 nm) phototherapy: a report of two cases","volume":"26","author":"Calzavara-Pinton","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0700","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1073\/pnas.0610534104","article-title":"Riboflavin activated by ultraviolet A1 irradiation induces oxidative DNA damage-mediated mutations inhibited by vitamin C","volume":"104","author":"Besaratinia","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0705","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.dnarep.2011.05.010","article-title":"Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation","volume":"10","author":"Brem","year":"2011","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0710","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archderm.144.7.851","article-title":"Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy","volume":"144","author":"Wang","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0715","first-page":"1","article-title":"UVA1 phototherapy: a concise and practical review","volume":"17","author":"Zandi","year":"2012","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.clindermatol.2013.01.011_bb0720","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1540-8183.2006.00205.x","article-title":"A new and rapid scoring system to assess the scientific evidence from clinical trials","volume":"19","author":"Silber","year":"2006","journal-title":"J Intervent Cardiol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T15:48:39Z","timestamp":1688312919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X13000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":144,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0738081X13000126"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2013.01.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}